Literature DB >> 31318590

Standardization of State Definitions for Neonatal Abstinence Syndrome Surveillance and the Opioid Crisis.

Katelyn V Chiang1, Ekwutosi M Okoroh1, Laurin J Kasehagen1, Luigi F Garcia-Saavedra1, Jean Y Ko1.   

Abstract

Rates of neonatal abstinence syndrome (NAS) have increased fivefold in the past decade. To address this expanding and complex issue, state public health agencies have addressed the opioid crisis affecting newborns in diverse ways, leading to a variety of methods to quantify the burden of NAS.In an effort to understand this variability, we summarized clinical case and surveillance definitions used across jurisdictions in the United States. We confirmed that the rapid progression of the nation's opioid crisis resulted in heterogeneous processes for identifying NAS. Current clinical case definitions use different combinations of clinician-observed signs of withdrawal and evidence of perinatal substance exposure. Similarly, there is discordance in diagnosis codes used in surveillance definitions. This variability makes it difficult to produce comparable estimates across jurisdictions, which are needed to effectively guide public health strategies and interventions.Although standardization is complicated, consistent NAS definitions would increase comparability of NAS estimates across the nation and would better guide prevention and treatment efforts for women and their infants.

Entities:  

Mesh:

Year:  2019        PMID: 31318590      PMCID: PMC6687235          DOI: 10.2105/AJPH.2019.305170

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014.

Authors:  Tyler N A Winkelman; Nicole Villapiano; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  Pediatrics       Date:  2018-04       Impact factor: 7.124

2.  Neonatal drug withdrawal.

Authors:  Mark L Hudak; Rosemarie C Tan
Journal:  Pediatrics       Date:  2012-01-30       Impact factor: 7.124

3.  Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.

Authors:  Hendrée E Jones; Karol Kaltenbach; Tara Benjamin; Elisha M Wachman; Kevin E O'Grady
Journal:  J Addict Med       Date:  2019 Mar/Apr       Impact factor: 3.702

Review 4.  Neonatal abstinence syndrome: an update.

Authors:  Lauren A Sanlorenzo; Ann R Stark; Stephen W Patrick
Journal:  Curr Opin Pediatr       Date:  2018-04       Impact factor: 2.856

5.  Recognition and management of iatrogenically induced opioid dependence and withdrawal in children.

Authors:  Jeffrey Galinkin; Jeffrey Lee Koh
Journal:  Pediatrics       Date:  2013-12-30       Impact factor: 7.124

6.  Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Authors:  Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-10       Impact factor: 17.586

7.  Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome - Six States, 2013-2017.

Authors:  Shahla M Jilani; Meghan T Frey; Dawn Pepin; Tracey Jewell; Melissa Jordan; Angela M Miller; Meagan Robinson; Tomi St Mars; Michael Bryan; Jean Y Ko; Elizabeth C Ailes; Russell F McCord; Julie Gilchrist; Sarah Foster; Jennifer N Lind; Lindsay Culp; Matthew S Penn; Jennita Reefhuis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-01-11       Impact factor: 17.586

  7 in total
  6 in total

1.  Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.

Authors:  Ashley H Hirai; Jean Y Ko; Pamela L Owens; Carol Stocks; Stephen W Patrick
Journal:  JAMA       Date:  2021-01-12       Impact factor: 56.272

Review 2.  Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.

Authors:  Martha L Velez; Chloe J Jordan; Lauren M Jansson
Journal:  Neurotoxicol Teratol       Date:  2021-08-19       Impact factor: 3.763

3.  Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.

Authors:  Charlan D Kroelinger; Donna Addison; Mirelys Rodriguez; Marion E Rice; Meghan T Frey; Hadley R Hickner; Mary Kate Weber; Trish Mueller; Alisa Velonis; Keriann Uesugi; Lisa Romero; Sanaa Akbarali; Natalie Foster; Jean Y Ko; Ellen Pliska; Christine Mackie; Shanna Cox; S Nicole Fehrenbach; Wanda D Barfield
Journal:  J Womens Health (Larchmt)       Date:  2020-03-13       Impact factor: 2.681

4.  Evaluating Definitions for Neonatal Abstinence Syndrome.

Authors:  Kathleen M Doherty; Theresa A Scott; Anna Morad; Travis Crook; Elizabeth McNeer; Kim S Lovell; James C Gay; Stephen W Patrick
Journal:  Pediatrics       Date:  2020-12-02       Impact factor: 7.124

5.  Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.

Authors:  Jean Y Ko; Jangho Yoon; Van T Tong; Sarah C Haight; Roshni Patel; Karilynn M Rockhill; Jeff Luck; Carrie Shapiro-Mendoza
Journal:  Drug Alcohol Depend       Date:  2021-04-20       Impact factor: 4.852

6.  Evaluation of State-Led Surveillance of Neonatal Abstinence Syndrome - Six U.S. States, 2018-2021.

Authors:  Shahla M Jilani; Kristina West; Laura Jacobus-Kantor; Mir M Ali; Alice Nyakeriga; Heather Lake-Burger; Meagan Robinson; A Elise Barnes; Tracey Jewell; Shayne Gallaway
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-01-14       Impact factor: 17.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.